Piramal Pharma Solutions plans to expand Lexington facility with USD 80 million investment

The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new laboratory, and state-of-the-art machinery. Key additions include a new filling line, two commercial-size lyophilizers, a special capping machine, and an external vial washer. Currently, the Lexington site can manufacture 104 product batches per year (utilization at peak levels). Upon completion of the expansion in Q1 of 2027, this capacity will increase to over 240 annual batches.

"This expansion represents a strategic investment in the future of Piramal Pharma Ltd. Filling the commercial manufacturing gap enables the Lexington site to access the rapidly expanding injectables market and establish itself as a key player in the segment," said Nandini Piramal, Chairperson, Piramal Pharma Ltd.

Significant research, development, and scientific innovation have driven rapid growth in the injectables market, with an expected market value exceeding $20B by 2028. This growth underscores the necessity for robust commercial-scale manufacturing capabilities.

As the efficiency and efficacy of injectable treatment options improve, more patients will benefit from these advanced therapies.

"The injectables market has steadily increased in recent years and there is currently insufficient supply. We are committed to adapting to meet this rising demand," said Peter DeYoung, Chief Executive Officer, Global Pharma. "This expansion will significantly enhance the capacity and capabilities of our Lexington facility, positioning Piramal Pharma as a comprehensive partner across the entire product life cycle and enabling us to provide treatment solutions to more patients."

The expansion will create over 40 full-time jobs.

"Kentucky's business-friendly climate, prime location and access to resources make it an ideal destination for companies to locate, expand and thrive," said Kentucky Governor Andy Beshear. "The decision by Piramal Pharma Solutions' leadership to expand and reinvest here is a testament to their trust and belief in what this great state has to offer. I want to thank the Company's leaders and wish Piramal Pharma continued success in Lexington."

Bob Quick, President and CEO of Commerce Lexington Inc., added, "Piramal Pharma Solutions' decision to expand its Lexington operations is a significant step forward for our region's economic growth. This investment not only demonstrates Piramal Pharma's confidence in our community and workforce but also underscores Lexington's position as a prime location for innovative companies to grow and thrive. We look forward to the positive impact this expansion will have on our local economy and the new opportunities it will create for our residents."